Details for Patent: 11,649,217
✉ Email this page to a colleague
Which drugs does patent 11,649,217 protect, and when does it expire?
Patent 11,649,217 protects JESDUVROQ and is included in one NDA.
This patent has six patent family members in six countries.
Drugs Protected by US Patent 11,649,217
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | JESDUVROQ | daprodustat | TABLET;ORAL | 216951-001 | Feb 1, 2023 | DISCN | Yes | No | 11,649,217 | ⤷ Subscribe | Y | A METHOD OF TREATING ANEMIA | ⤷ Subscribe | |||
| Glaxosmithkline | JESDUVROQ | daprodustat | TABLET;ORAL | 216951-002 | Feb 1, 2023 | DISCN | Yes | No | 11,649,217 | ⤷ Subscribe | Y | A METHOD OF TREATING ANEMIA | ⤷ Subscribe | |||
| Glaxosmithkline | JESDUVROQ | daprodustat | TABLET;ORAL | 216951-003 | Feb 1, 2023 | DISCN | Yes | No | 11,649,217 | ⤷ Subscribe | Y | A METHOD OF TREATING ANEMIA | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,649,217
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2018330994 | ⤷ Subscribe | |||
| Canada | 3112277 | ⤷ Subscribe | |||
| China | 111093668 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
